eli lilly retatrutide trial results An experimental weight-loss drug from looks like the most promising weight-loss drug ever tested, rivaling the of gastric bypass surgery. injections, designed to be taken once a week Eli Lilly retatrutide Phase 3

The right timing depends on body composition goals, metabolic health, eating patterns, insulin resistance, and whether sustainable habits have already developed

In 2025, VMAIL reported that the American Optometric Association (AOA) had released a clinical report by their evidence-based optometry committee warning of some serious ocular complications associated with GLP-1 receptor agonists, including exacerbation of age-related macular degeneration, progression of diabetic retinopathy and the rare but serious onset of NAION

The SPF mice exhibited decreased locomotor activity in the Ex-4-injected group (Fig

This represents approximately 28.6% of post-COVID IBS cases and 20% of general IBS cases

Wegovy uses higher amounts of semaglutide and comes in pens designed for weight loss